Xenetic Biosciences grants 100,000 restricted shares to Interim CEO James Parslow

Xenetic Biosciences, Inc.

Grant of 100,000 restricted shares to James Parslow, Interim CEO and CFO.
7,000 shares vest immediately; 31,000 vest on each of 1st, 2nd, 3rd anniversaries of April 21, 2026.
All unvested shares accelerate upon a Change in Control.
Award is under Amended and Restated Equity Incentive Plan; grant agreement filed as Exhibit 10.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.